Archivos de etiqueta: SARS-CoV-2

Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19

COVID-19, PublicationsPor Carlos del Fresno enero 11, 2022 Deja un comentario

We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination.

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity

COVID-19, PublicationsPor Carlos del Fresno noviembre 18, 2021 Deja un comentario

COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus.

SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown

COVID-19, PublicationsPor Carlos del Fresno noviembre 3, 2021 Deja un comentario

The Coronavirus Disease of 2019 (COVID-19) pandemic caused by SARS-CoV-2 led the Spanish government to impose a national lockdown in an attempt to control the spread of the infection.